RAD NEURIM PHARMACEUTICALS EEC SARL

It is used for the short-term treatment of primary insomnia (difficulty falling asleep, staying asleep, or poor sleep quality) in people over 55 years of age, when no medical, mental, or environmental cause has been identified.

Dosage form: tablets, prolonged-release

ATC: N05CH01

It is used for the short-term treatment of primary insomnia (difficulty falling asleep, staying asleep, or poor quality sleep) in patients over 55 years of age.

Dosage form: tablets, prolonged-release

ATC: N05CH01

It is used to treat insomnia in children and adolescents with autism spectrum disorders or neurogenetic diseases (between 2 and 18 years old) and in those with ADHD (between 6 and 17 years old), when a healthy sleep routine has not been sufficient.

Dosage form: tablets, prolonged-release

ATC: N05CH01